Monte Rosa Therapeutics Inc (GLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 7,509 | 34,590 | 46,885 | -72,700 | -86,137 |
| Depreciation Amortization | 6,268 | 4,173 | 2,048 | 8,121 | 6,060 |
| Accounts payable and accrued liabilities | -3,096 | -11,976 | -10,874 | 6,252 | -7,056 |
| Other Working Capital | -5,826 | -127,342 | -98,635 | 91,397 | -18,254 |
| Other Operating Activity | 15,361 | 20,343 | 15,084 | 8,926 | 18,461 |
| Operating Cash Flow | $20,216 | $-80,212 | $-45,492 | $41,996 | $-86,926 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -32,834 | -71,623 | -98,642 | -40,464 | -9,751 |
| PPE Investments | -3,933 | -3,282 | -1,587 | -3,988 | -3,805 |
| Investing Cash Flow | $-36,767 | $-74,905 | $-100,229 | $-44,452 | $-13,556 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 727 | 379 | 14 | 99,006 | 98,284 |
| Other Financing Activity | 0 | 0 | 0 | -114 | 0 |
| Financing Cash Flow | $727 | $379 | $14 | $98,892 | $98,284 |
| Beginning Cash Position | 229,117 | 229,117 | 229,117 | 132,681 | 132,681 |
| End Cash Position | 213,293 | 74,379 | 83,410 | 229,117 | 130,483 |
| Net Cash Flow | $-15,824 | $-154,738 | $-145,707 | $96,436 | $-2,198 |
| Free Cash Flow | |||||
| Operating Cash Flow | 20,216 | -80,212 | -45,492 | 41,996 | -86,926 |
| Capital Expenditure | -3,933 | -3,282 | -1,587 | -3,988 | -3,805 |
| Free Cash Flow | 16,283 | -83,494 | -47,079 | 38,008 | -90,731 |